Skip to main content
Log in

Interaction sites in the receptor-binding domain (RBD) of the spike wild-type SARS-CoV-2 protein of the posaconazole (POS) drug and its quantum–mechanical characterization

  • Original Paper
  • Published:
MRS Advances Aims and scope Submit manuscript

Abstract

We constructed a quantum model of the receptor-binding domain (RBD) of the wild-type SARS CoV-2 Spike protein, based on density-functional theory (DFT). Next, we interact it with the drug posaconazole (POS) and present the interactions and quantum mechanical properties of the RBD and POS. The research strategy of this work was through the interactions and electronic transition of the atoms that constitute RBD and the POS drug. We found and reported two interaction sites of the RBD-POS complex. Our results could explain the inhibitory effect of the POS drug on the reduction of virions reported in the treatment of patients infected with SARS CoV-2, due to the steric hindrance by not allowing the binding of the RBD to its human epithelial cell receptor ACE2.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

Data are available in supplementary material.

References

  1. X. Yang et al., Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. 8(5), 475481 (2020). https://doi.org/10.1016/S2213-2600(20)30079-5

    Article  Google Scholar 

  2. J.J. Zhang et al., Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan. China. Allergy 75(7), 1730–1741 (2020). https://doi.org/10.1111/all.14238

    Article  CAS  Google Scholar 

  3. T. Ahsan, A.A. Sayib, Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor. Biochem. Biophys. Rep. 26, 100982 (2021)

    CAS  Google Scholar 

  4. I. Maffucci, A. Contini, In silico drug repurposing for the main proteinase and spike proteins of SARS-CoV-2. J. Proteome Res. 19(11), 4637–4648 (2020)

    Article  CAS  Google Scholar 

  5. R. Volle et al., Methylene blue, Mycophenolic acid, Posaconazole, and Niclosamide inhibit SARS-CoV-2 Omicron variant BA.1 infection of human airway epithelial organoids. Curr. Res. Microb. Sci. (2022). https://doi.org/10.1016/j.crmicr

    Article  Google Scholar 

  6. K.G. Andersen, A. Rambaut, W.I. Lipkin, E.C. Holmes, R.F. Garry, The proximal origin of SARS-CoV-2. Nat. Med. 26, 450–452 (2020). https://doi.org/10.1038/s41591-020-0820-9

    Article  CAS  Google Scholar 

  7. J.P. Perdew, K. Burke, M. Ernzerhof, Generalized gradient approximation made simple. Phys. Rev. Lett. 78, 1396 (1997). https://doi.org/10.1103/PhysRevLett.78.1396

    Article  CAS  Google Scholar 

  8. Q. Li, F.T. Li, Recent advances in molecular oxygen activation via photocatalysis and its application in oxidation reactions. Chem. Eng. J. 421–1, 129915 (2021). https://doi.org/10.1016/j.cej.2021.129915

    Article  CAS  Google Scholar 

  9. S. Noorizadeh, K.A. Taghipour, A regioselectivity descriptor based on atomic Weizsäcker kinetic energy. Chem. Phys. Lett. 770, 138455 (2021). https://doi.org/10.1016/j.cplett.2021.138455

    Article  CAS  Google Scholar 

  10. R.G. Parr, W. Yang, Density functional approach to the frontier-electron theory of chemical reactivity. J. Am. Chem. Soc. 106(14), 4049–4050 (1984). https://doi.org/10.1021/ja00326a036

    Article  CAS  Google Scholar 

  11. R.G. Parr, W. Yang, Density functional theory of atoms and molecules (Oxford University Press, New York, 1989). https://doi.org/10.1093/oso/9780195092769.001.0001

    Book  Google Scholar 

Download references

Funding

J.C. Santiago-Jiménez acknowledges the support provided by Escuela Superior de Física y Matemáticas del Instituto Politécnico Nacional and CONAHCYT by doctoral scholarship 776574. F.L. Castillo-Alvarado acknowledges the support provided by SNI-CONAHCYT. G. Ramírez-Damaso acknowledges the support provided by SNI-CONAHCYT, SIP 20231566, and EDI-Instituto Politécnico Nacional. A. García-Quiroz acknowledges the support provided by the Universidad Autónoma de la Ciudad de México.

Author information

Authors and Affiliations

Authors

Contributions

All authors of the article worked in the same way. It was the result of our team of researchers.

Corresponding author

Correspondence to Juan Carlos Santiago-Jiménez.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author declares that there is no financial or personal conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 19 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Santiago-Jiménez, J.C., De Landa Castillo-Alvarado, F., García-Quiroz, A. et al. Interaction sites in the receptor-binding domain (RBD) of the spike wild-type SARS-CoV-2 protein of the posaconazole (POS) drug and its quantum–mechanical characterization. MRS Advances 8, 1279–1283 (2023). https://doi.org/10.1557/s43580-023-00666-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1557/s43580-023-00666-3

Navigation